Skip to main content
Premium Trial:

Request an Annual Quote

Single Technologies Raises $1.6M to Develop NGS Platform

NEW YORK – Single Technologies today announced it has raised SEK15 million ($1.6 million) to support further development of its next-generation sequencing platform.

Stockholm-based Single Technologies raised the funding via a convertible bond issue. JovB Holding, a Swedish investment firm, acted as the lead investor. The company said it will use the proceeds to support development of its products.

Called Theta, Single Technologies' platform relies on automated fluidics and single molecule-sensitive imaging to improve sequencing throughput. By enabling users to scale their sequencing projects, the company believes its technology will find use in population genomics and single-cell sequencing, among other applications.

CEO Johan Strömqvist said in a statement that Theta will enable "faster and more cost-efficient sequencing" in different sample types. He said the company intends to raise more funds before summer.

Single Technologies was founded in 2014 based on research into single-molecule imaging and biotechnology at the Royal Institute of Technology (KTH) in Stockholm, as well as on R&D in fiber optical grating done at Proximion, a fiber optics company based in Kista, Sweden.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.